PD-1 and TIGIT drugs for Hepatocellular Carcinoma
2 tracked PD-1 and TIGIT drugs in the Hepatocellular Carcinoma race. The class explanation lives on the PD-1 and TIGIT page; the full indication pipeline across every mechanism is on the Hepatocellular Carcinoma page.
2 Phase 3